Diana R. Kerwin
Advanced in Alzheimer's Disease

Dr. Diana R. Kerwin

Geriatrics | Internal Medicine
8198 Walnut Hill Ln, Ste 100, 
Dallas, TX 
On Staff At
Advanced in Alzheimer's Disease
8198 Walnut Hill Ln, Ste 100, 
Dallas, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Diana Kerwin is an Internal Medicine specialist and a Geriatrics provider in Dallas, Texas. Dr. Kerwin is rated as an Advanced provider by MediFind in the treatment of Alzheimer's Disease. Her top areas of expertise are Dementia, Alzheimer's Disease, Lewy Body Dementia (LBD), and Vascular Dementia.

Her clinical research consists of co-authoring 39 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 16 articles and participated in 10 clinical trials in the study of Alzheimer's Disease.

Graduate Institution
Medical College Of Wisconsin School Of Medicine - Registrar (1996)
Residency
Northwestern University/Feinberg School of Medicine - Medicine (1999)
Specialties
Geriatrics
Internal Medicine
Licenses
Geriatric Medicine in WI
Fellowships
Northwestern University/Feinberg School of Medicine - Geriatric (2000)
Hospital Affiliations
Texas Health Dallas
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Kerwin Research Center & Memory Care
8198 Walnut Hill Ln, Ste 100, Dallas, TX 75231

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: November 12, 2025
Intervention Type: Drug
Study Drugs: Gantenerumab, Solanezumab
Study Phase: Phase 2/Phase 3
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease
Enrollment Status: Active_not_recruiting
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease
Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: July 28, 2025
Intervention Type: Drug
Study Drug: LY3372689
Study Phase: Phase 2
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: ATH-1017
Study Phase: Phase 2/Phase 3
A Phase 3, Open-Label, Parallel-Group, 2-Arm Study to Investigate Amyloid Plaque Clearance With Donanemab Compared With Aducanumab-avwa in Participants With Early Symptomatic Alzheimer's Disease
A Phase 3, Open-Label, Parallel-Group, 2-Arm Study to Investigate Amyloid Plaque Clearance With Donanemab Compared With Aducanumab-avwa in Participants With Early Symptomatic Alzheimer's Disease
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Drug
Study Drugs: Donanemab, Aducanumab
Study Phase: Phase 3
GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects With Alzheimer's Disease
GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects With Alzheimer's Disease
Enrollment Status: Completed
Publish Date: February 23, 2023
Intervention Type: Drug
Study Drug: COR388
Study Phase: Phase 2/Phase 3
Development of a Biomarker Database to Investigate Aß, P-tau, and NfL Blood-Based Biomarkers and Digital Biomarkers in Older Participants Screened for Preclinical Alzheimer's Disease (AD), Prodromal AD, or Mild AD
Development of a Biomarker Database to Investigate Aß, P-tau, and NfL Blood-Based Biomarkers and Digital Biomarkers in Older Participants Screened for Preclinical Alzheimer's Disease (AD), Prodromal AD, or Mild AD
Enrollment Status: Completed
Publish Date: February 09, 2023
Intervention Type: Other
A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease
A Phase 2 Multiple Dose, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease
Enrollment Status: Completed
Publish Date: August 26, 2022
Intervention Type: Drug
Study Drug: Tilavonemab
Study Phase: Phase 2
Rare Diseases Clinical Research Network Advancing Research and Treatment for Frontotemporal Lobar Degeneration [ARTFL]: Research Projects 1 & 2
Rare Diseases Clinical Research Network Advancing Research and Treatment for Frontotemporal Lobar Degeneration [ARTFL]: Research Projects 1 & 2
Enrollment Status: Completed
Publish Date: May 21, 2021
18F-AV-1451 PET Imaging in Subjects With Frontotemporal Dementia
18F-AV-1451 PET Imaging in Subjects With Frontotemporal Dementia
Enrollment Status: Completed
Publish Date: September 25, 2020
Intervention Type: Drug, Procedure
Study Phase: Phase 1
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 11 Less Clinical Trials

39 Total Publications

A Functional Resting-State Network Atlas Based on 420 Older Adults with Hypertension.
A Functional Resting-State Network Atlas Based on 420 Older Adults with Hypertension.
Journal: bioRxiv : the preprint server for biology
Published: December 11, 2025
Similar Doctors
Distinguished in Alzheimer's Disease
Dr. Cindy D. Marshall
Psychiatry | Geriatrics
Distinguished in Alzheimer's Disease
Dr. Cindy D. Marshall
Psychiatry | Geriatrics

Healthtexas Provider Network

4001 Worth St, 
Dallas, TX 
 (5.9 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Cindy Marshall is a Psychiatrist and a Geriatrics provider in Dallas, Texas. Dr. Marshall is rated as a Distinguished provider by MediFind in the treatment of Alzheimer's Disease. Her top areas of expertise are Dementia, Alzheimer's Disease, Cerebellar Degeneration, and Vascular Dementia. Dr. Marshall is currently accepting new patients.

Distinguished in Alzheimer's Disease
Dr. Ihab M. Hajjar
Neurology | Geriatrics
Distinguished in Alzheimer's Disease
Dr. Ihab M. Hajjar
Neurology | Geriatrics

University Of Texas Southwestern Medical Center At Dallas

5303 Harry Hines Blvd, 
Dallas, TX 
 (6.8 miles away)
214-590-5601
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ihab Hajjar is a Neurologist and a Geriatrics provider in Dallas, Texas. Dr. Hajjar is rated as an Advanced provider by MediFind in the treatment of Alzheimer's Disease. His top areas of expertise are Alzheimer's Disease, Dementia, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, and Vascular Dementia. Dr. Hajjar is currently accepting new patients.

Distinguished in Alzheimer's Disease
Dr. Gene O. Bigham
Palliative Medicine | Geriatrics
Distinguished in Alzheimer's Disease
Dr. Gene O. Bigham
Palliative Medicine | Geriatrics
2727 Bolton Boone Dr, Suite 114, 
Desoto, TX 
 (17.5 miles away)
469-857-3142
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Gene Bigham is a Palliative Medicine specialist and a Geriatrics provider in Desoto, Texas. Dr. Bigham is rated as an Advanced provider by MediFind in the treatment of Alzheimer's Disease. His top areas of expertise are Alzheimer's Disease, Hypertension, Familial Hypertension, and Painful Swallowing. Dr. Bigham is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kerwin's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile